Results 181 to 190 of about 122,165 (292)
Oral nanoCEL exhibits effective intestinal targeting of antigen‐presenting cells and restores the Th17/Treg balance in lymph nodes and spleen, ultimately protecting the blood‐retinal barrier by inhibiting peripheral immune cell infiltration and suppressing retinal glial cell activation.
Jinrun Chen +13 more
wiley +1 more source
Prions in Muscles of Cervids with Chronic Wasting Disease, Norway. [PDF]
Vuong TT +9 more
europepmc +1 more source
This study identifies POLD4 as a potential prostate cancer radiosensitization target through transcriptome sequencing. By encapsulating POLD4‐targeted CRISPR/Cas9 plasmids and USPIONs in cationic liposomes, an MRI‐monitored gene‐editing platform is established.
Xuhui Fan +10 more
wiley +1 more source
Machine learning-assisted characterization of cervid skin tissues with chronic wasting disease by nano-enabled Raman spectroscopic biosensing. [PDF]
Tong T +6 more
europepmc +1 more source
Prenatal dexamethasone exposure (PDE) programs persistent podocyte developmental injury and adult glomerulosclerosis. Mechanistically, glucocorticoid receptor (GR) binds the miR‐135a‐5p promoter and recruits the histone acetyltransferase p300, increasing promoter histone acetylation and sustaining miR‐135a‐5p expression. Elevated miR‐135a‐5p suppresses
Xiaoqi Zhao +8 more
wiley +1 more source
Homogenization Reveals Large-Scale Dynamics in the Spread of Chronic Wasting Disease. [PDF]
McClure J, Powell J.
europepmc +1 more source
This study delineates macrophage heterogeneity along the acute kidney injury to chronic kidney disease transition. Single‐cell RNA sequencing reveals a TRAP5+ scar‐associated macrophage subset driven by Spp1–Cd44 signaling and mitochondrial metabolic reprogramming.
Chenxi Wang +13 more
wiley +1 more source
Detection and Decontamination of Chronic Wasting Disease Prions during Venison Processing. [PDF]
Milstein M +14 more
europepmc +1 more source
Nutrition Social Behavior Change and Communication (SBCC) guidance [PDF]
Ekesa, Beatrice +3 more
core
This study tests NeuroD1 AAV‐based gene therapy in a non‐human primate Alzheimer's disease model. The therapy prevents neuronal damage, inhibits hippocampal atrophy, and reduces neuroinflammation. It also repairs vascular and blood‐brain barrier damage, restores cerebrospinal fluid biomarkers, enhances hippocampal glucose metabolism, and improves ...
Zhouquan Jiang +21 more
wiley +1 more source

